DKSH has expanded its exclusive distribution agreement with Exsymol, a global pioneer in high-performance cosmetic ingredients, to South Korea. Through this partnership, DKSH will accelerate the growth of Exsymol’s signature active ingredients, including its silanol-based technologies, in the market. This partnership follows the successful collaboration in Canada.
Zurich, Switzerland, July 24, 2025 – DKSH’s Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients will provide business development, marketing, sales, logistics, and distribution services for Exsymol’s portfolio of active ingredients, including its signature silanol technology based on organic silicium, as well as peptides and natural actives, in South Korea.
Exsymol is recognized for its proven active ingredients, particularly silanols derived from organic silicium, which help rejuvenate the skin, reduce visible signs of aging, and support long-term skin health. Exsymol also offers peptides and natural actives, adding to a versatile range of innovative ingredients that help brands to develop and enhance leading skincare solutions.
Following their successful collaboration in Canada, Exsymol has once again chosen DKSH to expand its presence in South Korea. This decision is driven by DKSH’s strong formulation expertise, regulatory knowledge, and deep understanding of the local market.
Ori Callot, Global Commercial, Marketing and Communication Director, Exsymol, commented: “We are very happy to extend our partnership with DKSH to South Korea. A great distribution partner is more than a logistics provider, it is the strategic extension of our business, ensuring our products reach the right customers, in the right market, at the right time. By opening doors to new opportunities, strengthening local presence, and delivering operational excellence, DKSH ensures service quality on our behalf. Having unique expert technology in Exsymol, we must find the right partner in each market. That is why we give our full trust to DKSH and welcome this strong and strategic partnership.”
Michelle Delac, Vice President, Global Personal Care Industry, DKSH, commented: “We are proud to strengthen our partnership with Exsymol through this strategic expansion into South Korea. This collaboration reflects our shared commitment to staying close to local market needs while driving global growth. Exsymol’s proven actives, particularly its silanol technology, closely align with the performance and innovation demands of today’s skincare industry. We look forward to supporting cosmetic brands with high-quality solutions that meet the needs of this dynamic market.”
About Exsymol
Founded in Monaco in 1972, Exsymol is a scientific and industrial company specializing in the development of active ingredients for the cosmetics industry. With expertise in molecular design and skin biology, Exsymol offers a portfolio that includes silanols, peptides, bio-boosters, and natural extracts, all supported by strong scientific validation. The company is committed to safety, efficacy, and sustainability, delivering high-performance ingredients manufactured to international quality standards. www.exsymol.com/en
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. With 58 innovation centers and regulatory support worldwide, DKSH creates cutting-edge formulations that comply with local regulations. With around 1,720 specialists, the Business Unit generated net sales of CHF 1.4 billion in 2024. www.dksh.com/pm